All.Can around the world

According to World Health Organization comparisons, Australian cancer patients generally have better cancer survival rates than those in other countries. In the last 30 years, the death rate for cancer in Australia has dropped by more than 24%.

The quality of cancer care in Belgium, as measured by five-year survival for treatable cancers such as breast cancer, cervical cancer and colorectal cancer, is better than the EU average.

One in every two Canadians is expected to develop some type of cancer during their lifetime, with one in four expected to die from their disease. The economic burden of cancer care in Canada is substantial.

In Germany, quality of cancer care is at its highest and access to treatment is generally not restricted. However, challenges remain.

Compared to other European Union countries, both health spending in general and spending on cancer care in Poland, measured as a percentage of GDP per capita, are very low.

In 2015, Spain had the highest life expectancy among EU countries. Nevertheless, cancer remains the leading cause of death for Spanish men and second-leading cause of death for Spanish women, after cardiovascular disease.

The quality of cancer care in Sweden is high and survival rates for many types of cancer are above the European average. Although the economic and social impact of cancer on society is lower than the European average, Sweden spends more than an average European country on cancer relative to its incidence.

Switzerland is known for having one of the best healthcare systems in the world, but its main challenges lie in becoming more cost-effective.

The UK spends more money on healthcare than the rest of Europe, but allocates much less of its health spending to cancer (3.8%) than the EU average (5%). UK survival rates lag behind much of Europe.